Thomas Schachtner (0000-0001-5549-4798)

Personal information

Biography

2022 Granting of the Executive MBA diploma of the University of St. Gallen (HSG), CH
2020-2022 International Executive MBA program at the University of St. Gallen (HSG), CH
Since 2020 Attending physician at the University Hospital Zurich, Division of Nephrology, CH
2020 Permission to teach Internal Medicine (facultas docendi and venida legendi) at the University of Zurich, CH
2019 Acquisition of the title “Specialist in Nephrology”
2018-2019 Specialist Training in Nephrology at University Hospital Zurich, CH
2017 Permission to teach Internal Medicine (facultas docendi and venida legendi) at the Charité University Medicine Berlin, Germany
Granting of the academic title “Privatdozent”
Acquisition of the title “Specialist in Hypertension”
2017 Acquisition of the title “Specialist in Internal Medicine”
2012/2013 Abdominal Ultrasound, Duplex Ultrasound, and Echocardiography Certification, German Society of Ultrasound in Medicine and Biology (DEGUM)
2011-2018 Specialist Training in Internal Medicine at Charité Universitätsmedizin Berlin, Campus Virchow Clinic, Berlin, Germany
2011 Approbation als Arzt (License to practice medicine)
2. Abschnitt der Ärztlichen Prüfung (Second National Medical License Examination) at Charité Universitätsmedizin Berlin, Germany
2006-2011 Medical studies at Charité Universitätsmedizin Berlin, Germany
2006 1. Abschnitt der Ärztlichen Prüfung (First National Medical License Examination) at Ludwig-Maximilian University and Tech University of Munich, Germany
2004-2006 Medical studies at Ludwig-Maximilian and Tech University of Munich, Germany
2003/2004 Obligatory civilian service at Kreiskrankenhaus (County hospital) Erding, Germany
2003 Abitur Certificate (Certificate of General University Entrance Qualification)

Activities

Collapse all

Universität Zürich: Zurich, ZH, CH

Employment

Thomas Schachtner

https://orcid.org/0000-0001-5549-4798

Personal information

Other IDs

Countries

Biography

Activities

Employment (4)

Universität Zürich: Zurich, ZH, CH

Universitätsspital Zürich: Zurich, Switzerland, DE

Universitätsspital Zürich: Zurich, Switzerland, DE

Charite Universitatsmedizin Berlin - Campus Virchow-Klinikum Zentralbibliothek: Berlin, Berlin, DE

Education and qualifications (4)

Universität St. Gallen: St. Gallen, St. Gallen, CH

Charite Universitätsmedizin Berlin: Berlin, Berlin, DE

Charite Universitätsmedizin Berlin: Berlin, Berlin, DE

Charite Universitätsmedizin Berlin: Berlin, Berlin, DE

Professional activities (9)

Swiss Society of Nephrology: Bern, Bern, CH

International Society of Nephrology: Cranford, NJ, US

American Society of Transplantation: Mount Laurel, New Jersey, US

ERA-EDTA Registry: Amsterdam, Noord-Holland, NL

European Patent Office: Munich, Bavaria, DE

The Transplantation Society: Montreal, QC, CA

American Society of Transplantation: Mount Laurel, New Jersey, US

American Society of Transplantation: NJ, NJ, US

American Society of Transplantation: Mount Laurel, New Jersey, US

Funding (3)

Calibrating the donor-derived cell-free DNA (DD-cfDNA) baseline in the first year after kidney transplantation to the Predicted Indirectly Recognizable HLA-Epitopes (PIRCHE-II) scores

Adoptive T-cell therapy with enrichment of central memory T-cells in solid organ transplant recipients with CMV infection resistant to antiviral therapy

Adoptive T-cell therapy with enrichment of central memory T-cells in solid organ transplant recipients with CMV infection resistant to antiviral therapy

Works (43)

Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients

PIRCHE-II scores prove useful as a predictive biomarker among kidney transplant recipients with rejection: An analysis of indication and follow-up biopsies

Impact of different urinary tract infection phenotypes within the first year post‐transplant on renal allograft outcomes

Surgical site infections after simultaneous pancreas kidney and pancreas transplantation in the Swiss Transplant Cohort Study

Cancer among kidney transplant recipients &amp;gt;20 years after transplantation: post-transplant lymphoproliferative disorder remains the most common cancer type in the ultra long-term

Long-term outcomes of transplant kidneys donated after circulatory death

Clinical spectrum of gross haematuria following SARS-CoV-2 vaccination with mRNA vaccines

Effects of Artificial Intelligence-Derived Body Composition on Kidney Graft and Patient Survival in the Eurotransplant Senior Program

High PIRCHE Scores May Allow Risk Stratification of Borderline Rejection in Kidney Transplant Recipients

Cohort profile: The Swiss Transplant Cohort Study (STCS): A nationwide longitudinal cohort study of all solid organ recipients in Switzerland

Pre‐transplant donor‐specific HLA antibodies and risk for poor first‐year renal transplant outcomes: results from the Swiss Transplant Cohort Study

Use of letermovir-valganciclovir combination as a step-down treatment after foscarnet for ganciclovir-resistant CMV infection in kidney transplant recipients.

Intravenous immunoglobulins do not prove beneficial to reduce alloimmunity among kidney transplant recipients with BKV‐associated nephropathy

Kidney transplant monitoring by urinary flow cytometry: Biomarker combination of T cells, renal tubular epithelial cells, and podocalyxin-positive cells detects rejection

Two decades of the Eurotransplant Senior Program: the gender gap in mortality impacts patient survival after kidney transplantation

Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial

Preformed donor‐reactive T cells that persist after ABO desensitization predict severe T cell‐mediated rejection after living donor kidney transplantation – a retrospective study

Cyclosporine use and male gender are independent determinants of avascular necrosis after kidney transplantation: a cohort study

Impact of acute kidney injury on neurological outcome and long-term survival after cardiac arrest – A 10 year observational follow up

Ex vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapy

Differential T cell response against BK virus regulatory and structural antigens: A viral dynamics modelling approach

Transplantectomy is associated with presensitization with donor-reactive T cells and graft failure after kidney retransplantation: a cohort study

Factors and outcomes in association with sepsis differ between simultaneous pancreas/kidney and single kidney transplant recipients

CMV-Specific T Cell Monitoring Offers Superior Risk Stratification of CMV-Seronegative Kidney Transplant Recipients of a CMV-Seropositive Donor

Simultaneous pancreas/kidney transplant recipients are predisposed to tissue-invasive cytomegalovirus disease and concomitant infectious complications

Diabetic kidney transplant recipients: Impaired infection control and increased alloreactivity

Estimated Nephron Number of the Donor Kidney: Impact on Allograft Kidney Outcomes

Sepsis after renal transplantation: Clinical, immunological, and microbiological risk factors

Increased alloreactivity and adverse outcomes in obese kidney transplant recipients are limited to those with diabetes mellitus

Kidney transplant recipients after nonrenal solid organ transplantation show low alloreactivity but an increased risk of infection

Pretransplant prophylactic rituximab to prevent Epstein-Barr virus (EBV) viremia in EBV-seronegative kidney transplant recipients from EBV-seropositive donors: results of a pilot study

Zytomegalievirus nach Nierentransplantation

Estimated nephron number of the remaining donor kidney: impact on living kidney donor outcomes

Simultaneous pancreas/kidney transplant recipients present with late-onset BK polyomavirus-associated nephropathy

ABO desensitization affects cellular immunity and infection control after renal transplantation

Different risk factor profiles distinguish early-onset from late-onset BKV-replication

The Loss of BKV-specific Immunity From Pretransplantation to Posttransplantation Identifies Kidney Transplant Recipients at Increased Risk of BKV Replication

Current characteristics and outcome of cytomegalovirus infections after kidney transplantation

Inflammatory activation and recovering BKV-specific immunity correlate with self-limited BKV replication after renal transplantation

Mannose-binding lectin deficiency is not associated with increased risk for polyomavirus nephropathy

Novel Approach for Improved Assessment of Phenotypic and Functional Characteristics of BKV-Specific T-Cell Immunity

BK Virus-Specific Immunity Kinetics: A Predictor of Recovery From Polyomavirus BK-Associated Nephropathy

BK-VP3 as a New Target of Cellular Immunity in BK Virus Infection

Peer review (2 reviews for 2 publications/grants)

Cancer among kidney transplant recipients >20 years after transplantation: post-transplant lymphoproliferative disorder remains the most common cancer type in the ultra long-term

Impact of acute kidney injury on neurological outcome and long-term survival after cardiac arrest – A 10 year observational follow up